Aspen Neuroscience's amended bylaws take effect at IPO closing

Aspen Neuroscience’s amended and restated bylaws became effective Nov. 2, 2026, in connection with its IPO closing. The offering comprised 9,375,000 common shares at $15 each and generated approximately $140.6 million in gross proceeds before discounts, commissions and expenses.